Drug Type Small molecule drug |
Synonyms Compound 2j(Seoul National University&Future Medicine) |
Target |
Action agonists |
Mechanism A2aR agonists(Adenosine A2a receptor agonists), A3R agonists(Adenosine A3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | South Korea | 01 Jan 2026 | |
| Inflammation | Preclinical | South Korea | 01 Jan 2026 |





